New glutathione formula shows promise in small study
NCT ID NCT06345950
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new micellar form of the antioxidant glutathione in 16 healthy adults. Researchers compared how well it was absorbed versus standard and liposomal glutathione capsules over 30 days. The goal was to see if the new formulation leads to higher levels in the blood and is safe to take.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- glutathione (dietary supplement)
- What this could lead to
- If successful, this could lead to a more effective glutathione supplement for general health support.
- What could go wrong
- This is a very small, early-stage study in healthy volunteers, so results may not apply to people with health conditions. The supplement is not a treatment for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
16 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
Dec 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * male or female aged 21-65 years * healthy, good physical condition * voluntary, written, informed consent to participate in the study. Exclusion Criteria: * use of anti-inflammatory or non-steroidal anti-inflammatory drugs * previous history of cardiovascular disease or acute or chronic inflammatory disease * use of antioxidant supplements or cholesterol-lowering agents * change of diet habits or lifestyle (diet, physical activity, etc.) * alcohol or substance abuse history * use of nicotine or tobacco * participation in another investigational study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bioavailability heathy volunteers are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ISURA
Burnaby, British Columbia, V2N 4S9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new cosmetic pass the skin allergy test?
- Can a new drug pair tame hodgkin lymphoma in older patients?
- Can a new injection shrink advanced solid tumors?
- Can a two-drug combo better tame prostate trouble?
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- Tiny study checks if novel bacterium is safe for people